Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more ...

Leela Barham highlights data that shows that indication-specific pricing has been used in England for at least four years and over 60 times. Lessons from that experience should be used to provide ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a supplemental new drug application that updates the indication statement for upadacitinib ...

The US Food and Drug Administration has expanded the indication for evolocumab (Repatha) to include a wider swath of patients at high risk for cardiovascular disease due to elevated LDL cholesterol ...

Previously, Repatha was indicated to reduce the risk of MACE in patients with established cardiovascular disease. The Food and Drug Administration (FDA) has expanded the approval of Repatha ® ...

Three clinical trials have examined the efficacy and safety of single dose azithromycin (30 mg/kg) in children with uncomplicated acute otitis media (AOM). In the first trial, a small pilot study, the ...

Among hospitalized patients with community-acquired pneumonia, those treated with azithromycin plus beta-lactams had lower in-hospital mortality and mortality rates at 30 and 90 days post-admission ...

Depending on its form, Medicare Part D or Original Medicare may cover azithromycin. People enrolled in Part C will get the same coverage. Azithromycin (Zithromax) is an antibiotic that doctors often ...

Efforts to reduce child mortality in Africa via mass treatment with the antibiotic azithromycin (AZM) may lead to increased drug resistance in bacteria that frequently cause pneumonia and meningitis, ...

Please provide your email address to receive an email when new articles are posted on . Azithromycin for 5 days was studied against placebo. Futility analyses stopped this trial early. Being negative ...